Status:
ACTIVE_NOT_RECRUITING
Implementation of Actinic Keratosis Guideline Among General Practitioners.
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Actinic Keratoses
Eligibility:
All Genders
18+ years
Brief Summary
This study investigates 5-fluorouracil cream prescription trends by general practitioners for the treatment of field changes of actinic keratosis over the years 2016-2021. The aim is to analyse whethe...
Detailed Description
Actinic keratosis is the most common epithelial precancerous lesion among the Caucasian race. With an increase in prevalence worldwide due to an aging population and rise of ultraviolet exposure actin...
Eligibility Criteria
Inclusion
- age \>18 years
- diagnosis actinic keratosis (clinical diagnosed or by biopsy)
Exclusion
- cutaneous malignancy (suspicion)
- immunosuppressive co-medication.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05976048
Start Date
March 1 2020
End Date
December 1 2025
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ellen Oyen
Maastricht, Netherlands